$BETRF News

Last published 1y ago

1y agoBETRFBetterLife Announces Debt SettlementsGlobeNewswireVANCOUVER, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development of BETR-001, a
1y agoBETRFBetterLife Announces Debt ConversionsGlobeNewswireVANCOUVER, British Columbia, March 10, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development of BETR-001, a
1y agoBETRFUSPTO Grants BetterLife's BETR-001 Composition of Matter PatentGlobeNewswireVANCOUVER, British Columbia, Jan. 14, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development of BETR-001, a
1y agoBETRFBetterLife Announces Favorable Outcome in New York Legal ClaimsGlobeNewswireVANCOUVER, British Columbia, Dec. 09, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development of BETR-001, a non-hallucinogenic
1y agoBETRFBetterLife Obtains Favourable Cardiac Safety Data for BETR-001GlobeNewswireVANCOUVER, British Columbia, Nov. 25, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development of BETR-001, a
2y agoBETRFBetterLife Obtains Favourable Genotoxicity Data for Oral BETR-001GlobeNewswireVANCOUVER, British Columbia, Oct. 23, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development of BETR-001, a
2y agoBETRFBetterLife Announces Fully Subscribed Private Placement FinancingGlobeNewswireVANCOUVER, British Columbia, Aug. 29, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and
2y agoBETRFBetterLife Highlights Advantages of Non-hallucinogenic LSD Derivative BETR-001 and Publication of its Methods to Treat Mood Disorders PatentGlobeNewswireVANCOUVER, British Columbia, Aug. 27, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development of 2-bromo-LSD
2y agoBETRFAmendment of Disclosures in Past Management Information CircularsGlobeNewswireVANCOUVER, British Columbia, July 16, 2024 (GLOBE NEWSWIRE) -- As a result of a review by the British Columbia Securities Commission, BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an
2y agoBETRFBetterLife Announces Closing of a Private PlacementGlobeNewswireVANCOUVER, British Columbia, July 02, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and
2y agoBETRFBetterLife To Present BETR-001 Preclinical Data at the 2024 Conference of the Federation of European Neuroscience Societies (FENS) in Vienna, AustriaGlobeNewswireVANCOUVER, British Columbia, June 26, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and
2y agoBETRFBetterLife Announces Closing of a Private PlacementGlobeNewswireVANCOUVER, British Columbia, June 14, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and
2y agoBETRFBetterLife Obtains Excellent Animal Cardiopulmonary Safety Data for Oral BETR-001GlobeNewswireVANCOUVER, British Columbia, May 14, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development of BETR-001, a
2y agoBETRFBetterLife Announces Intent to Complete Private Placement of UnitsGlobeNewswireVANCOUVER, British Columbia, May 03, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and commercialization
2y agoBETRFBetterLife Advances BETR-001 IND-enabling StudiesGlobeNewswireVANCOUVER, British Columbia, May 01, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and commercialization
2y agoBETRFBetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor ConferenceGlobeNewswireVANCOUVER, British Columbia, April 11, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and
2y agoBETRFBetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001GlobeNewswireVANCOUVER, British Columbia, April 03, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and
2y agoBETRFBetterLife's 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton UniversityGlobeNewswireVANCOUVER, British Columbia, March 04, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and
2y agoBETRFBetterLife Announces Closing of Convertible Debentures For Further Development of BETR-001GlobeNewswireVANCOUVER, British Columbia, Jan. 02, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and
2y agoBETRFBetterLife Announces Closing of a Private PlacementGlobeNewswireVANCOUVER, British Columbia, Dec. 18, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and
2y agoBETRFBetterLife Announces Extension of WarrantsGlobeNewswireVANCOUVER, British Columbia, Nov. 30, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and
2y agoBETRFUS Patent and Trademark Office Publishes BetterLife's Comprehensive Patent for BETR-001 and Other LSD DerivativesGlobeNewswireVANCOUVER, British Columbia, Nov. 15, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and
3y agoBETRFBetterLife Pharma to Host Investors Update Call on September 18, 2023GlobeNewswireVANCOUVER, British Columbia, Sept. 14, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development of BETR-001, a
3y agoBETRFBetterLife Obtains Favourable Animal Safety Data for Repeated Oral Dosing of BETR-001GlobeNewswireVANCOUVER, British Columbia, Sept. 12, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development of BETR-001, a
3y agoBETRFBetterLife Highlights BETR-001 Article in Technology Networks Drug Discovery and Announces Closing of a Private PlacementGlobeNewswireVANCOUVER, British Columbia, Sept. 05, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and
3y agoBETRFBetterLife Highlights American College of Physicians' Updated Guidelines for Treating Depression and Announces Closing of Private PlacementGlobeNewswireVANCOUVER, British Columbia, July 13, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and
3y agoBETRFBetterLife Fast Tracks Its US Patent for BETR-001 and Other LSD DerivativesGlobeNewswireVANCOUVER, British Columbia, June 27, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and
3y agoBETRFBetterLife To Present BETR-001 Preclinical Data at the 32nd Annual Meeting of the International Behavioural Neuroscience Society (IBNS) in Niagara Falls, Ontario, CanadaGlobeNewswireVANCOUVER, British Columbia, June 22, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and
3y agoBETRFBetterLife Continues Progress on BETR-001 IND-Enabling StudiesGlobeNewswireVANCOUVER, British Columbia, June 08, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and
3y agoBETRFBetterLife To Present BETR-001 Preclinical Data at the 2023 Annual Meeting of the Society of Biological Psychiatry (SOBP) in San Diego, CaliforniaGlobeNewswireVANCOUVER, British Columbia, April 25, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and
3y agoBETRFBetterLife To Present at the 2023 Bloom Burton & Co. Healthcare Investor ConferenceGlobeNewswireVANCOUVER, British Columbia, April 20, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and
3y agoBETRFBetterLife's Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Drug Discovery & Development ArticleGlobeNewswireVANCOUVER, British Columbia, March 29, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and
3y agoBETRFPromise of BetterLife's Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Medical Xpress ArticleGlobeNewswireVANCOUVER, British Columbia, March 22, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and
3y agoBETRFBetterlife Publishes Promising Results from a Study Titled "A Non-Hallucinogenic LSD Analog With Therapeutic Potential For Mood Disorders"GlobeNewswireVANCOUVER, British Columbia, March 09, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and
3y agoBETRFBetterLife Announces Engagement of Bloom Burton Securities Inc. and Provides Summary of 2022 AccomplishmentsGlobeNewswireVANCOUVER, British Columbia, Jan. 26, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and
3y agoBETRFBetterLife To Present BETR-001 Preclinical Data at the 61ST Annual Meeting of the American College of Neuropsychopharmacology (ACNP) in Phoenix, ArizonaGlobeNewswireVANCOUVER, British Columbia, Dec. 02, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and
4y agoBETRFBetterLife Files Comprehensive Patent for BETR-001 and Other LSD DerivativesGlobeNewswireVANCOUVER, British Columbia, Sept. 27, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for
4y agoBETRFBetterLife and Collaborators to Submit Key Joint Research PublicationGlobeNewswireVANCOUVER, British Columbia, Sept. 07, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for
4y agoBETRFBetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity with Possible Nootropic Effects Similar to That of LSD Without Hallucinogenic Side EffectsGlobeNewswireVANCOUVER, British Columbia, Aug. 24, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), is an emerging biotech company focused on the development and commercialization of cutting-edge treatments fo
4y agoBETRFBetterLife Secures Additional Mitacs Funding in Collaboration with Carleton University Research Team for BETR-001 Preclinical Depression StudiesGlobeNewswireVANCOUVER, British Columbia, July 06, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for m
4y agoBETRFBetterLife To Participate at the H.C. Wainwright 1st Annual Mental Health ConferenceGlobeNewswireVANCOUVER, British Columbia, June 23, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for m
4y agoBETRFBetterLife To Present BETR-001 Preclinical Data at the Upcoming Federation of European Neuroscience Societies (FENS) ForumGlobeNewswireVANCOUVER, British Columbia, June 21, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for m
4y agoBETRFBetterLife To Present BETR-001 Preclinical Data at the Upcoming Canadian Association for Neuroscience ConferenceGlobeNewswireVANCOUVER, British Columbia, April 21, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for
4y agoBETRFBetterLife's BETR-001 Demonstrates BETR-001 Anti-depressant Activity in Preclinical Models of DepressionGlobeNewswireVANCOUVER, British Columbia, April 06, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for
4y agoBETRFBetterLife Obtains In Vivo PK Data for BETR-001 Confirming its Bioavailability in BrainGlobeNewswireVANCOUVER, British Columbia, March 16, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and commercialization of second generation non-halluc
4y agoBETRFBetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity in Preclinical ModelGlobeNewswireVANCOUVER, British Columbia, Feb. 15, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and commercialization of 2nd generation non-hallucinog
4y agoBETRFBetterLife Receives FDA Response On Its Pre-IND Application For Major Depressive Disorder (MDD) Treatment With BETR-001GlobeNewswireVANCOUVER, British Columbia, Jan. 20, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and commercialization of 2nd-generation non-hallucinog
4y agoBETRFBetterLife Obtains Positive In Vivo Oral Bioavailability, Food Effect and Pharmacokinetics Data for BETR-001GlobeNewswireVANCOUVER, British Columbia, Jan. 18, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and commercialization of 2nd-generation non-hallucinog
4y agoBETRFDr. Eleanor Fish, Advisory Board Member, Awarded Order of CanadaGlobeNewswireVANCOUVER, British Columbia, Jan. 06, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for m
4y agoBETRFBetterLife Obtains Positive TD-0148A Data in Preclinical Models of DepressionGlobeNewswireVANCOUVER, British Columbia, Dec. 09, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for m